13.94
+0.49(+3.64%)
Currency In USD
| Previous Close | 13.45 |
| Open | 13.28 |
| Day High | 14.24 |
| Day Low | 13.2 |
| 52-Week High | 69.97 |
| 52-Week Low | 12.35 |
| Volume | 312,660 |
| Average Volume | 411,047 |
| Market Cap | 178.27M |
| PE | 0.05 |
| EPS | 279.15 |
| Moving Average 50 Days | 15.91 |
| Moving Average 200 Days | 26.24 |
| Change | 0.49 |
If you invested $1000 in Tonix Pharmaceuticals Holding Corp. (TNXP) 10 years ago, it would be worth $0 as of March 09, 2026 at a share price of $13.94. Whereas If you bought $1000 worth of Tonix Pharmaceuticals Holding Corp. (TNXP) shares 5 years ago, it would be worth $0.02 as of March 09, 2026 at a share price of $13.94.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Tonix Pharmaceuticals Presented Data on TONMYA™ in Treating Patients with Fibromyalgia at the 2026 AAPM PainConnect Annual Meeting
GlobeNewswire Inc.
4 hours ago
TONMYA (cyclobenzaprine HCl sublingual tablets) for the treatment of fibromyalgia in adults, was commercially launched in November 2025Treatment with TONMYA provided statistically significant pain reduction in two Phase 3 trials and was generally wel
Tonix Pharmaceuticals Presented Data on TONMYATM in Treating Patients with Fibromyalgia at the 2026 AAPM PainConnect Annual Meeting
GlobeNewswire Inc.
4 hours ago
TONMYA (cyclobenzaprine HCl sublingual tablets) for the treatment of fibromyalgia in adults, was commercially launched in November 2025 Treatment with TONMYA provided statistically significant pain reduction in two Phase 3 trials and was generally we
Tonix Pharmaceuticals Announces Publication of Clinical Pharmacokinetic Studies of TONMYA™ and Prototype Formulations in the Journal Clinical Pharmacology in Drug Development
GlobeNewswire Inc.
Mar 05, 2026 9:15 PM GMT
Commercially launched in the U.S. in November 2025, TONMYA (cyclobenzaprine HCl sublingual tablets) for long-term daily dosing at bedtime is the first new FDA-approved treatment for fibromyalgia in adults in more than 15 years The sublingual TONMYA t